Oncoinfluencers to Follow on Social Media: Dr. Patrick Hwu
We are excited to introduce Dr. Patrick Hwu, a leading expert in cancer immunotherapy, as our next oncoinfluencer.
Dr. Wang is active on X/Twitter, where he shares his expertise and updates on the latest advancements in lymphoma research. His posts provide valuable insights into preclinical and clinical research, particularly in Mantle Cell Lymphoma (MCL). His frequent updates and thought-provoking contributions make him a must-follow for anyone interested in lymphoma research and treatment.
Follow Dr. Patrick Hwu on X/Twitter and LinkedIn to stay informed about his latest research and contributions to cancer immunotherapy.
About Patrick Hwu
Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T-cell therapy.
He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.
Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research.
Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023